Nikanfar Masoud, Taheri-Aghdam Ali Akbar, Yazdani Maria, Shaafi Sheida, Masoudian Nooshin, Akbari Hossein, Youhanaee Parisa, Abbaszadeh Hamzeh
Department of Neurology, Neuroscience Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Neurology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Iran J Neurol. 2015 Jan 5;14(1):17-21.
It seems that serum vitamin D levels are one of the potential environmental factors affecting the severity of multiple sclerosis (MS). In this study, we aim to evaluate vitamin D levels in MS patients and healthy subjects and assess the relationship between vitamin D level and disability.
In this case-control study, 168 rapid relapsing MS patients and 168 matched healthy controls were randomly included in this study. Demographic characteristics and serum vitamin D levels for patients and controls, as well as expanded disability status scale (EDSS), duration of disease and diagnostic lag for patients were evaluated. We followed up patients for 6 months and relapses were recorded.
The mean serum vitamin D levels were 19.16 ± 17.37 inpatients and 25.39 ± 19.67 in controls (P = 0.560). The mean serum vitamin D levels were 12.65 ± 13.3 in patients with relapses and 22.08 ± 18.22 in patients without any relapses (P < 0.001). There was no significant correlation between EDSS score and serum vitamin D levels (r = -0.08, P = 0.280). There was a significant positive correlation between EDSS score and disease duration (r = 0.52, P < 0.001).
In conclusion, vitamin D level in patients with MS was significantly lower than the healthy subjects, but no significant relationship was found between vitamin D levels and disability. Our findings did not suggest a protective role for serum vitamin D levels against disability.
血清维生素D水平似乎是影响多发性硬化症(MS)严重程度的潜在环境因素之一。在本研究中,我们旨在评估MS患者和健康受试者的维生素D水平,并评估维生素D水平与残疾之间的关系。
在这项病例对照研究中,168例快速复发型MS患者和168例匹配的健康对照者被随机纳入本研究。评估了患者和对照者的人口统计学特征、血清维生素D水平,以及患者的扩展残疾状态量表(EDSS)、病程和诊断延迟。我们对患者进行了6个月的随访,并记录复发情况。
患者的血清维生素D平均水平为19.16±17.37,对照者为25.39±19.67(P = 0.560)。复发患者的血清维生素D平均水平为12.65±13.3,无复发患者为22.08±18.22(P < 0.001)。EDSS评分与血清维生素D水平之间无显著相关性(r = -0.08,P = 0.280)。EDSS评分与病程之间存在显著正相关(r = 0.52,P < 0.001)。
总之,MS患者的维生素D水平显著低于健康受试者,但未发现维生素D水平与残疾之间存在显著关系。我们的研究结果并未表明血清维生素D水平对残疾具有保护作用。